Physician profile
Michael G Kim
NPI 1295136406
$4,981.09
in general payments reported to CMS, 2019-2025
11 companies · $1,697 in 2025
The $1,697 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $475 · 2023: $565 · 2024: $1,787 · 2025: $1,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,198 · Honoraria: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,198.30 |
| Honoraria | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,839.63 | 2023-2025 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Gs Solutions, INC. | $850.00 | 2024 | |
| Stryker Corporation | $457.74 | 2021-2022 | |
| Globus Medical, INC. | $291.13 | 2022-2024 | Excelsius3d Imaging System, Si-Lok, Bendini |
| Medtronic, INC. | $133.30 | 2022-2025 | Mazor X System |
| Abbott Laboratories | $130.54 | 2021 | |
| Medical Device Business Services, INC. | $77.38 | 2024 | Teligen |
| Depuy Synthes Sales INC. | $76.30 | 2022 | |
| Irras USA, INC. | $49.11 | 2022 | |
| Nevro Corp. | $45.90 | 2022-2023 | Senza |
| Bioventus LLC | $30.06 | 2024 | Bonescalpel & Sonicone (O.R.) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.